Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031515 | tRNA (m1A) methyltransferase complex | 6 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0034708 | methyltransferase complex | 4 | 12 |
GO:0043527 | tRNA methyltransferase complex | 5 | 12 |
GO:1902494 | catalytic complex | 2 | 12 |
GO:1990234 | transferase complex | 3 | 12 |
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IIA8
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0030488 | tRNA methylation | 5 | 1 |
GO:0032259 | methylation | 2 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008175 | tRNA methyltransferase activity | 5 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016426 | tRNA (adenine) methyltransferase activity | 6 | 12 |
GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity | 7 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.423 |
CLV_NRD_NRD_1 | 323 | 325 | PF00675 | 0.370 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 322 | 324 | PF00082 | 0.363 |
CLV_PCSK_PC1ET2_1 | 292 | 294 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 324 | 328 | PF00082 | 0.527 |
DOC_MAPK_gen_1 | 322 | 333 | PF00069 | 0.502 |
DOC_MAPK_MEF2A_6 | 28 | 36 | PF00069 | 0.492 |
DOC_PP2B_LxvP_1 | 228 | 231 | PF13499 | 0.312 |
DOC_PP4_FxxP_1 | 216 | 219 | PF00568 | 0.339 |
DOC_PP4_FxxP_1 | 286 | 289 | PF00568 | 0.388 |
DOC_USP7_MATH_1 | 219 | 223 | PF00917 | 0.450 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.520 |
DOC_USP7_UBL2_3 | 344 | 348 | PF12436 | 0.683 |
DOC_WW_Pin1_4 | 251 | 256 | PF00397 | 0.300 |
DOC_WW_Pin1_4 | 40 | 45 | PF00397 | 0.364 |
LIG_14-3-3_CanoR_1 | 306 | 310 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 324 | 333 | PF00244 | 0.405 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.645 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.317 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.329 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.394 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.328 |
LIG_LIR_Apic_2 | 214 | 219 | PF02991 | 0.340 |
LIG_LIR_Apic_2 | 284 | 289 | PF02991 | 0.318 |
LIG_LIR_Gen_1 | 224 | 235 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 315 | 325 | PF02991 | 0.354 |
LIG_LIR_LC3C_4 | 31 | 36 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 183 | 188 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 224 | 230 | PF02991 | 0.289 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 315 | 320 | PF02991 | 0.342 |
LIG_PDZ_Class_1 | 348 | 353 | PF00595 | 0.725 |
LIG_Pex14_2 | 287 | 291 | PF04695 | 0.474 |
LIG_SH2_STAP1 | 111 | 115 | PF00017 | 0.303 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 317 | 320 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.536 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.312 |
LIG_SUMO_SIM_anti_2 | 112 | 119 | PF11976 | 0.302 |
LIG_SUMO_SIM_anti_2 | 31 | 37 | PF11976 | 0.366 |
LIG_SUMO_SIM_anti_2 | 86 | 93 | PF11976 | 0.340 |
LIG_WRC_WIRS_1 | 250 | 255 | PF05994 | 0.318 |
LIG_WRC_WIRS_1 | 317 | 322 | PF05994 | 0.313 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.543 |
MOD_Cter_Amidation | 126 | 129 | PF01082 | 0.450 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.303 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.303 |
MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.380 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.337 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.303 |
MOD_GSK3_1 | 308 | 315 | PF00069 | 0.427 |
MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.418 |
MOD_N-GLC_2 | 239 | 241 | PF02516 | 0.423 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.318 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.388 |
MOD_NEK2_1 | 249 | 254 | PF00069 | 0.318 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.318 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.691 |
MOD_NEK2_1 | 305 | 310 | PF00069 | 0.564 |
MOD_PIKK_1 | 104 | 110 | PF00454 | 0.295 |
MOD_PIKK_1 | 180 | 186 | PF00454 | 0.423 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.292 |
MOD_PIKK_1 | 97 | 103 | PF00454 | 0.308 |
MOD_PK_1 | 85 | 91 | PF00069 | 0.519 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.400 |
MOD_PKA_2 | 294 | 300 | PF00069 | 0.375 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.656 |
MOD_PKA_2 | 305 | 311 | PF00069 | 0.514 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.545 |
MOD_PKB_1 | 298 | 306 | PF00069 | 0.517 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.344 |
MOD_Plk_2-3 | 276 | 282 | PF00069 | 0.303 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.497 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.522 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.445 |
MOD_ProDKin_1 | 251 | 257 | PF00069 | 0.300 |
MOD_ProDKin_1 | 40 | 46 | PF00069 | 0.365 |
MOD_SUMO_for_1 | 326 | 329 | PF00179 | 0.534 |
TRG_DiLeu_BaEn_1 | 86 | 91 | PF01217 | 0.547 |
TRG_ENDOCYTIC_2 | 317 | 320 | PF00928 | 0.337 |
TRG_ER_diArg_1 | 322 | 324 | PF00400 | 0.363 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA18 | Leptomonas seymouri | 86% | 100% |
A0A0S4IUX6 | Bodo saltans | 57% | 100% |
A0A1X0NRB0 | Trypanosomatidae | 63% | 100% |
A0A3R7LPM7 | Trypanosoma rangeli | 64% | 100% |
A4I3X1 | Leishmania infantum | 100% | 100% |
A6H791 | Bos taurus | 36% | 100% |
D0A938 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 84% |
E9AIT3 | Leishmania braziliensis | 89% | 100% |
E9B061 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
O14307 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 97% |
P0CS08 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 36% | 82% |
P0CS09 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 36% | 82% |
P46959 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 35% | 92% |
P9WFZ0 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 29% | 100% |
P9WFZ1 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 29% | 100% |
Q2U3W4 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 31% | 74% |
Q4Q824 | Leishmania major | 93% | 98% |
Q4WUT7 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 29% | 70% |
Q5A416 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 34% | 100% |
Q6AY46 | Rattus norvegicus | 36% | 100% |
Q6BX32 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 32% | 96% |
Q6C0P9 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 33% | 91% |
Q6CN53 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 34% | 87% |
Q6FL77 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 33% | 94% |
Q755M8 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 34% | 87% |
Q80XC2 | Mus musculus | 36% | 100% |
Q86JJ0 | Dictyostelium discoideum | 32% | 100% |
Q96FX7 | Homo sapiens | 36% | 100% |
Q9V1J7 | Pyrococcus abyssi (strain GE5 / Orsay) | 26% | 100% |
V5BC39 | Trypanosoma cruzi | 63% | 100% |